Swiss National Bank
INFI

Swiss National Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Swiss National Bank’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-77,900
Closed -$122K – 2573
2016
Q3 		$122K Hold
77,900
– – ﹤0.01% 2533
2016
Q2 		$104K Sell
77,900
-5,100
-6% -$23.9K ﹤0.01% 2574
2016
Q1 		$423K Buy
83,000
+15,000
+22% +$91.8K ﹤0.01% 2388
2015
Q4 		$534K Hold
68,000
– – ﹤0.01% 2223
2015
Q3 		$575K Buy
68,000
+8,300
+14% +$76.6K ﹤0.01% 2116
2015
Q2 		$654K Buy
59,700
+6,500
+12% +$83.4K ﹤0.01% 2070
2015
Q1 		$744K Hold
53,200
– – ﹤0.01% 1928
2014
Q4 		$899K Hold
53,200
– – ﹤0.01% 1796
2014
Q3 		$714K Hold
53,200
– – ﹤0.01% 1863
2014
Q2 		$678K Buy
53,200
+6,000
+13% +$62.5K ﹤0.01% 1966
2014
Q1 		$561K Buy
47,200
+9,300
+25% +$125K ﹤0.01% 2065
2013
Q4 		$523K Buy
37,900
+8,600
+29% +$121K ﹤0.01% 1958
2013
Q3 		$511K Sell
29,300
-1,700
-5% -$32.6K ﹤0.01% 1920
2013
Q2 		$504K Buy
+31,000
New +$959K ﹤0.01% 1914

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swiss National Bank's INFI Position: Q4 2016 in Review

Swiss National Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 77,900 shares — an estimated $122K sold.

Swiss National Bank first reported a position in INFI in Q2 2013 and held it in 14 quarters. The position peaked at $899K in Q4 2014. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • Swiss National Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Swiss National Bank sold 77,900 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $122K.
  • Swiss National Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • Swiss National Bank's Infinity Pharmaceuticals, Inc. position peaked at $899K in Q4 2014.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Swiss National Bank's 13F filing for Q4 2016, filed 8 Feb 2017.